How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,960 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review

information, i.e., in the context of available resources and circumstances presented by individual patients. This report is made available to the public under the terms of a licensing agreement between the author and the Agency for Healthcare Research and Quality. This report may be used and reprinted without permission except those copyrighted materials that are clearly noted in the report. Further reproduction of those copyrighted materials is prohibited without the express permission of copyright

2019 Effective Health Care Program (AHRQ)

142. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned

of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients. This report is made available to the public under the terms of a licensing agreement between the authors and the Agency for Healthcare Research and Quality. This report may be used and reprinted without permission except those copyrighted materials that are clearly noted (...) : Measure Definitions and Data Element Descriptions 13 Development of Standardized Terminologies 13 Leveraging Existing Resources 14 Public Comment 15 Challenges and Lessons Learned 16 Next Steps 16 Implementation 16 Dissemination 17 Ongoing Governance 17 Additional Clinical Areas 17 References 19 Abbreviations 21 Tables Table 1. Steps in registry identification process 6 Table 2. Stakeholder participation rationale 8 Table 3. Registry and stakeholder organization participation, by clinical area 8 Table

2019 Effective Health Care Program (AHRQ)

143. Measurement of Blood Pressure in Humans

. For example, the UK National Institute for Health and Care Excellence guideline recommends that patients obtain ≥14 daytime readings for an ABPM recording to be considered complete. The 2016 Canadian Hypertension education program guidelines criteria for a successful ABPM include requiring that at least 70% of planned readings are valid, with a minimum of 20 daytime and 7 nighttime readings, while the 2018 European Society of Cardiology/ESH guideline requires 70% of planned readings to be valid. , Until

2019 American Heart Association

144. Primary Prevention of Cardiovascular Disease

Recommendations for ASCVD Prevention Efforts 11 2.1. Patient-Centered Approaches to Comprehensive ASCVD Prevention 11 2.2. Assessment of Cardiovascular Risk 14 3. Lifestyle Factors Affecting Cardiovascular Risk 18 3.1. Nutrition and Diet 18 3.2. Exercise and Physical Activity 21 4. Other Factors Affecting Cardiovascular Risk 24 4.1. Adults with Overweight and Obesity 24 4.2. Adults with Type 2 Diabetes Mellitus 26 4.3. Adults with High Blood Cholesterol 30 4.4. Adults with High Blood Pressure or Hypertension (...) in the routine primary prevention of ASCVD because of lack of net benefit. 9. Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low- density lipoprotein cholesterol levels (=190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion. 10. Nonpharmacological interventions are recommended for all adults with elevated blood pressure or hypertension. For those

2019 American College of Cardiology

145. Management of Rotator Cuff Injuries

by the systematic literature review development group and published in the Journal of the American Academy of Orthopaedic Surgeons, and articles published in AAOS Now. Selected clinical practice guidelines are disseminated by webinar, AAOS Online Learning, the Orthopaedic Video Theater (OVT), Media Briefings, and by distributing them at relevant Continuing Medical Education (CME) courses and at the AAOS Resource Center. 24 View background material via the RC CPG eAppendix 1 View data summaries via the RC CPG (...) research. This guideline is intended to be used by all qualified and appropriately trained physicians and surgeons involved in the management of rotator cuff tears. It is also intended to serve as an information resource for decision makers and developers of practice guidelines and recommendations. GOALS AND RATIONALE The purpose of this clinical practice guideline is to help improve treatment based on the current best evidence. Current evidence-based medicine (EBM) standards demand that physicians use

2019 American Academy of Orthopaedic Surgeons

146. American Society for Parenteral and Enteral Nutrition Clinical Guidelines: The Validity of Body Composition Assessment in Clinical Populations

muscle IMAT (area), paraspinal IMAT (area), and psoas IMAT (area) (CT) Time between body composition cholesterol, tests not stated Spearman correlations reported There were significant correlations between % BF (DXA) and VAT (area), SAT (area), abdominal muscle IMAT (area), paraspinal IMAT (area), and psoas IMAT (area) (CT) (all P ‐values < 0.0001) Mourtzakis et al, 2008 To evaluate regional CT images acquired during routine patient care as a potential resource to discriminate and to quantify (...) reported There were significant correlations between FM (DXA) vs TAAT (CT), FM (DXA) vs TSAT (CT), FM (DXA) vs SSAT (CT), and FM (DXA) vs VAT (CT) (all P ‐values < 0.0001) There were significant correlations between total cholesterol, total triglycerides, total ApoB, VLDL cholesterol, VLDL triglycerides, ApoB, LDL cholesterol, LDL triglycerides, and LDL ApoB vs VAT (CT) (all P ‐values < 0.0001) There were significant correlations between HDL cholesterol ( P = 0.02), HDL triglcerides ( P = 0.002), HDL2

Full Text available with Trip Pro

2019 American Society for Parenteral and Enteral Nutrition

147. Treatment of Diabetes in Older Adults

remark: This recommendation is most applicable to high-risk patients with any of the following characteristics: overweight or obese, first-degree relative with diabetes, high-risk race/ethnicity ( e.g. , African American, Latino, Native American, Asian American, Pacific Islander), history of cardiovascular disease, hypertension (≥140/90 mm Hg or on therapy for hypertension), high-density lipoprotein cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L), sleep (...) levels for reducing absolute cardiovascular disease events and all-cause mortality. (1|⊕⊕⊕⊕) Technical remark: The Writing Committee did not rigorously evaluate the evidence for specific low-density lipoprotein cholesterol targets in this population, so we refrained from endorsing specific low-density lipoprotein cholesterol targets in this guideline. For patients aged 80 years old and older or with short life expectancy, we advocate that low-density lipoprotein cholesterol goal levels should

2019 The Endocrine Society

148. Registries for Evaluating Patient Outcomes: A User's Guide: Fourth Edition (Draft)

of Competency of Personnel 271 3.1.3. Data Quality Audits 271 3.2. Registry Procedures and Systems 273 3.2.1. External Audits of Registry Procedures 273 3.2.2. Assurance of System Integrity and Security 273 3.2.3. System Development and Validation 273 3.3. Security 274 3.3.1. System Security Plan 274 3.3.2. Security Assessment 274 3.3.3. Education and Training 274 3.3.4. Access Rights 274 3.3.5. Access Controls 275 3.3.6. Data Enclaves 275 3.3.7. Electronic Signatures 275 3.3.8. Validation 276 4. Resource (...) . Patient Outcomes 42 2.8.3. The Role of Patient-Reported Outcomes in Registries 43 2.8.4. Target Population 44 2.9. Develop a Study Plan or Protocol 45 2.10. Develop a Project Plan 45 3. Anticipating and Preparing for Change 46 4. Special Considerations 47 4.1. Rare Disease Registries 47 4.2. Quality Improvement Registries 48 5. Resources for Registries 48 6. Summary 49 References for Chapter 2 50 Chapter 3. Registry Design 56 1. Introduction 56 2. Research Questions Appropriate for Registries 57 3

2019 Effective Health Care Program (AHRQ)

149. Management of Stroke Rehabilitation

- specific goals, values, and preferences. B. Guide patients on self-management during stroke rehabilitation as well as on use of other resources that are available to assist them with their ADLs. C. Assist patients with navigating the complex health system. D. Provide patients and family, and their caregivers with education and health information to improve understanding of stroke, common comorbidities, and stroke rehabilitation management. Materials need to be individualized to preferred learning (...) comprehensive care and rehabilitation starting early in the post-acute phase. G. Create a support system for patients with stroke and their caregivers. Suggested actions include monthly provider-facilitated meetings either in-person or online groups, other support groups, and stroke education classes to enhance involvement and support among patients with stroke. H. Screen for, identify, and treat post-stroke depression. I. Provide home care and community support resources to optimize quality of life

2019 VA/DoD Clinical Practice Guidelines

150. Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies

, , , , , , , , , , , , and March 2017 , , , , , , , , , , , , , , , , and April 2017 April 23, 2019 Vol 139, Issue 17 Article Information Metrics Download : 687 © 2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. PubMed Originally published March 20, 2019 Keywords Subjects Title Title Title Title Circulation AHA Journals Journal Information Subjects Features Resources & Education For Authors & Reviewers National Center 7373 Greenville Ave. Dallas, TX 75231 Customer Service 1-800 (...) . Guidelines on bradycardia and cardiac conduction delay and blood cholesterol management were the first to be written de novo in this format. Elements of the modular knowledge chunk are shown in ; an example of the general appearance of the modular knowledge chunk is given in . Table 1. The Modular Knowledge Chunk Table of related recommendations with class of recommendation and level of evidence Synopsis Brief summary, which may include important background information, overarching management

Full Text available with Trip Pro

2019 American Heart Association

151. Methodology for Creating Expert Consensus Decision Pathways

already be addressed in Clinical Practice Guidelines, but additional expert consensus guidance may be needed where evidence is limited or evolving, and/or suf?cient data is lacking to support practicing clinicians in making treatment decisions. Whilenospeci?cnumberofExpertConsensusDecision Pathways has been established for a given year, the oversight committee considers the limitations in resources and the acuity of the need for guidance in determining which topics will be pursued and which (...) Related to Heart House Roundtables Expert Consensus Decision Pathways Published in 2016 Non-Statin Therapies For LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk Expert Consensus Decision Pathways Published in 2017 Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation Focused Update: Non-Statin Therapies For LDL-Cholesterol Lowering

2019 American College of Cardiology

152. Sudden Hearing Loss

presents with sudden hearing loss. (KAS 7) Clinicians should educate patients with sudden sensorineural hearing loss about the natural history of the condition, the benefits and risks of medical interventions, and the limitations of existing evidence regarding efficacy. (KAS 13) Clinicians should counsel patients with sudden sensorineural hearing loss who have residual hearing loss and/or tinnitus about the possible benefits of audiologic rehabilitation and other supportive measures. These strong (...) of treatment and also within 6 months posttreatment is added. KAS 13—This statement on audiologic rehabilitation includes patients who have residual hearing loss and/or tinnitus who may benefit from treatment. Addition of an algorithm outlining KASs Enhanced emphasis on patient education and shared decision making with tools provided to assist in same Keywords , , , , , Introduction Sudden hearing loss (SHL) is a frightening symptom that often prompts an urgent or emergent visit to a clinician

2019 American Academy of Otolaryngology - Head and Neck Surgery

153. Surgery to Reduce the Risk of Ovarian Cancer Information for Women at Increased Risk

Resources Centre for Genetics Education, NSW Health www.genetics.edu.au (Including family cancer clinic contacts and genetic support groups) Ovarian Cancer Australia www.ovariancancer.net.au Cancer Australia www.canceraustralia.gov.au Australasian Menopause Society www.menopause.org.au Cancer Council NSW www.cancercouncil.com.au REFERENCES 1. Cancer in Australia (2017) AIHW 2. Woodward et al. (2007). Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk (...) Surgery to Reduce the Risk of Ovarian Cancer Information for Women at Increased Risk Surgery to Reduce the Risk of Ovarian Cancer Information for Women at Increased Risk2 © Centre for Genetics Education NSW Health 2017 The Centre for Genetics Education NSW Health Level 5 2C Herbert St St Leonards NSW 2065 Ph: 02 9462 9599 Fax: 02 9906 7529 Email: contact@genetics.edu.au Website: www.genetics.edu.au Copies of this booklet can be ordered from the Centre for Genetics Education or downloaded from

2019 European Society of Endocrinology

154. Integrated care for older people (?ICOPE)?: guidance for person-centred assessment and pathways in primary care

the combined impact of rapidly falling fertility rates and rapidly increasing life expectancy in much of the world, often accompanying socioeconomic development. Maintaining the health of older people is an investment in human and social capital and supports the United Nations Sustainable Development Goals (SDGs) (4). At the same time, caring for the growing older population creates challenges for health systems. Health-care resources will need to be rebalanced across age groups. A fundamental change (...) (palliative care, rehabilitation) or to ensure that older people can continue to live lives of meaning and dignity; • social care and support, including environmental adaptations, to compensate for any functional losses; and • a plan to meet social care needs with the help of family members, friends and community services. Health and social care workers can support the implementation of the care plan in the community or the primary care setting. Self-management, supported by advice, education

2019 World Health Organisation Guidelines

155. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

Health Education Consortium, Joint-Base San Antonio, Texas , MD y , x Jashin J. Wu Affiliations Dermatology Research and Education Foundation, Irvine, California , MD z , x Vidhya Hariharan Affiliations American Academy of Dermatology, Rosemont, Illinois Correspondence Correspondence to: Vidhya Hariharan, PhD, 9500 W Bryn Mawr Ave, Rosemont, IL 60018. , PhD aa , ∗ , x Vidhya Hariharan Affiliations American Academy of Dermatology, Rosemont, Illinois Correspondence Correspondence to: Vidhya Hariharan (...) inhibitor. ---- | Fig 5 From: Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation . 2013 ( ). x 87 Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report

2019 American Academy of Dermatology

156. Access to Hormonal Contraception

- tinued their pill use (P5.12) (20). Additionally, when adjustingfordifferences(age,countryofbirth,country where education was completed, U.S. health insurance status, receipt of government assistance, border- crossing frequency, duration of use of OCPs, experi- ence of adverse effects attributable to OCPs, and how long the woman reported she planned to use OCPs), a higher rate of discontinuation for women who ob- tained pills in El Paso clinics (25.1%) compared with those who obtained their pills (...) purchased combined OCPs over-the-counter in this study did not self-screen using a standardized process and the circumstances of patients (eg, lacking access to primary care) may have affected the outcome. Pharmacist screening for behind-the-counter access to hormonal contraceptive methods also has been evaluated. In the Direct Access Study, several pharma- cists received specialized education in the provision of hormonal contraceptive methods and were authorized to provide hormonal contraception

2019 American College of Obstetricians and Gynecologists

157. Cardiac rehabilitation

concordance 20 9 Provision of information 21 9.1 Checklist for provision of information 21 9.2 Sources of further information 22 10 Implementing the guideline 25 10.1 Implementation strategy 25 10.2 Resource implications of key recommendations 25 10.3 Auditing current practice 25 11 The evidence base 26 11.1 Systematic literature review 26 11.2 Recommendations for research 26 11.3 Review and updating 27 12 Development of the guideline 28 12.1 Introduction 28 12.2 The guideline development group .28 12.3 (...) replaces the old four phase model with a 0–6 stage pathway including individualised assessment and care planning. 4 The standards describe a biopsychosocial approach to CR in which the overall aim is to equip the patient with the necessary knowledge and skills to enable them to successfully self manage their condition to live a longer, healthier, and more independent life. The approach is centred on patient education using health behaviour change techniques, which are patient centred and sensitive both

2017 SIGN

158. Pharmacological management of glycaemic control in people with type 2 diabetes

36 13.1 Implementation strategy 36 13.2 Resource implications of key recommendations 36 13.3 Auditing current practice 36 13.4 Health technology assessment advice for NHSScotland 36 14 The evidence base 37 14.1 Systematic literature review 37 14.2 Recommendations for research 38 15 Development of the guideline 39 15.1 Introduction 39 15.2 The guideline development group 39 15.3 Consultation and peer review 40 Abbreviations 42 Annex 1 45 References 46 Pharmacological management of glycaemic (...) (hyperglycaemia) is also one of the features of diabetes, along with raised blood pressure and cholesterol, which is associated with macrovascular complications (myocardial infarction, stroke, and peripheral arterial disease). The effects of glucose-lowering therapies on cardiovascular morbidity and mortality are therefore of major importance and not necessarily related to glucose lowering. Until 2010, the majority of clinical trials focused narrowly on glucose control (as assessed by HbA1c (glycated

2017 SIGN

159. Risk estimation and the prevention of cardiovascular disease

and the prevention of cardiovascular disease Contents9.4 Antiplatelet agents for people with hypertension 38 9.5 Antiplatelet agents for people with chronic kidney disease 38 10 Lipid lowering 39 10.1 The role of total and low-density lipoprotein cholesterol in cardiovascular disease 39 10.2 Measuring lipid levels 39 10.3 Lowering cholesterol to reduce cardiovascular risk 40 10.4 Statin therapy 40 10.5 Special considerations 48 10.6 Other lipid-lowering agents 51 10.7 Management of combined dyslipidaemia 55 11 (...) Implementing the guideline 74 14.1 Implementation strategy 74 14.2 Resource implications of key recommendations 74 14.3 Auditing current practice 74 14.4 Health technology assessment advice for NHSScotland 75 15 The evidence base 76 15.1 Systematic literature review 76 15.2 Recommendations for research 77 16 Development of the guideline 78 16.1 Introduction 78 16.2 The guideline development group 78 16.3 The steering group 79 16.4 Consultation and peer review 80 Abbreviations 82 Annexes 85 References 99

2017 SIGN

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>